The cost of altepase has more than doubled over the past ten years in the USA, whilst US Medicare/Medicaid reimbursement has lagged far behind, a presentation from the American Stroke Association’s International Stroke Conference (ISC 2016) has reported.
The identification of patients likely to benefit from stroke clot removal may be made more accurate with the use of brain imaging, rather than relying on the amount of time since symptoms began, according to research presented at the American Stroke Association’s International Stroke Conference (ISC 2016).
Higher pollution levels have been associated with a higher total number of strokes, according to research presented at the American Stroke Association’s International Stroke Conference (ISC 2016).
The rapid improvement of symptoms before arrival at hospital does not always lead to better recovery for stroke patients, according to new research presented at the American Stroke Association International Stroke Conference (ISC 2016).
A clinical trial has found no significant differences between the use of carotid-artery stenting and carotid endarterectomy over a period of five years for the prevention of strokes in asymptomatic patients with serious narrowing of the carotid artery.
Mercy Life Flight Network and Samsung Neurologica have announced the debut of a mobile stroke unit (MSU) serving Northwestern Ohio, USA residents. This is the fourth unit of its kind in the USA.
Long-term follow-up results of the CREST trial show no significant difference between patients who underwent stenting and those who underwent endarterectomy with respect to the risk of periprocedural stroke, myocardial infarction, or death and subsequent ipsilateral stroke at 10 years. The rate of postprocedural ipsilateral stroke also did not differ between groups.
Medtronic is to launch the OsteoCool radiofrequency ablation system for surgeons who treat patients with painful spinal metastases. The system has been granted US Food and Drug Administration (FDA) 510(k) marketing clearance.
At the 2015 annual meeting of the European Society of Minimally Invasive Neurological Therapy (ESMINT; 10–12 September, Nice, France) Gyula Gal (Department of Radiology, University Hospital Odense, Denmark) reported his experience with the PulseRider aneurysm neck reconstruction device (Pulsar Vascular/Codman Neuro).
A study has found that twice-daily stimulation of the vagus nerve with the hand-held gammaCore non-Invasive Nerve Stimulation (nVNS) device has reduced the number of headaches days per month from 14.7 to 8.9 (p<0.001) days per patient. The number of monthly migraine attacks observed was reduced from 7.3 to 4.5 (p<0.0001).
vasopharm Gmbh has raised €20 million of new capital, which it intends to use to fully fund a pivotal, European phase III study of its product, VAS 203, in patients with moderate-to-severe traumatic brain injury.
In the last year, five prospective randomised clinical trials have demonstrated the superiority of endovascular thrombectomy over medical management for the treatment of acute ischaemic stroke.
Endovascular coiling has made a huge impact on the treatment of intracranial aneurysms. Since the advent of the GDC coil 25 years ago, there has been growing body of evidence that support its use over surgical clipping in subarachnoid haemorrhage, and consequently its popularity has grown in the treatment of unruptured aneurysms as well. Now, more aneurysms than ever before are being coiled and volumes will increase further as coil and catheter technology continues to improve.
Neuravi has announced commercial availability of the company’s EmboTrap Revascularisation Device for the treatment of acute ischaemic stroke in Europe. The device will be marketed through the sales and distribution network the company has established in Belgium, Denmark, Finland, France, Germany, Ireland, Italy, the Netherlands, Norway, Spain, Sweden and Switzerland.
Now that the safety and efficacy of mechanical thrombectomy for the treatment of acute ischaemic stroke has been proven in at least five randomised controlled trials, there is some worry within the community that the pressure to deliver this therapy to all appropriate patients will result in inexperienced operators attempting to do the procedures. But who are the ideal operators?
Cookies Sociales
Son esos botones que permiten compartir el contenido del sitio web en sus redes sociales (Facebook, Twitter y Linkedin, previo tu consentimiento y login) a través de sistemas totalmente gestionados por dichas redes sociales, así como los recursos (pej. videos) y material que se encuentra en nuestra web, y que de igual manera se presta y gestiona completamente por un tercero.
Si no acepta estas cookies, no podrá compartir nuestro contenido a través de los botones, y en su caso, no podrás visualizar el contenido de terceros que hayamos incrustado en el sitio.
No las utilizamos